The microbiome modulating activity of bile acids

References

• Wahlstrom A, Sayin SI, Marschall HU, Backhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41–50. doi:10.1016/j.cmet.2016.05.005.
   Google Scholar
• Urdaneta V, Casadesus J. Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts. Front Med. 2017;4:163.
   Google Scholar
• Ma C, Han MJ, Heinrich B, Fu Q, Zhang QF, Sandhu M, Agdashian D, Terabe M, Berzofsky JA, Fako V, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360:eaan5931.
   Google Scholar
• Tian Y, Cai J, Gui W, Nichols RG, Koo I, Zhang J, Anitha M, Patterson AD. Berberine directly affects the gut microbiota to promote intestinal farnesoid X receptor activation. Drug Metab Dispos. 2019;47:86–93. doi:10.1124/dmd.118.083691.
   Google Scholar
• Begley M, Hill C, Gahan CGM. Bile salt hydrolase activity in probiotics. App Environ Microb. 2006;72:1729–1738. doi:10.1128/AEM.72.3.1729-1738.2006.
   Google Scholar
• Li F, Jiang CT, Krausz KW, Li YF, Albert I, Hao HP, Fabre KM, Mitchell JB, Patterson AD, Gonzalez FJ. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun. 2013;4:1–10.
   Google Scholar
• Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016;7:22–39. doi:10.1080/19490976.2015.1127483.
   Google Scholar
• Lorenzo-Zuniga V, Bartoli R, Planas R, Hofmann AF, Vinado B, Hagey LR, Hernández JM, Mañé J, Alvarez MA, Ausina V, et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology. 2003;37:551–557. doi:10.1053/jhep.2003.50116.
   Google Scholar
• Inagaki T, Moschetta A, Lee YK, Peng L, Zhao GX, Downes M, Yu RT, Shelton JM, Richardson JA, Repa JJ, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. P Natl Acad Sci USA. 2006;103:3920–3925. doi:10.1073/pnas.0509592103.
   Google Scholar
• Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. Identification of a nuclear receptor for bile acids. Science. 1999;284:1362–1365. doi:10.1126/science.284.5418.1362.
   Google Scholar
• Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science. 1999;284:1365–1368. doi:10.1126/science.284.5418.1365.
   Google Scholar
• Wang HB, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR BAR. Mol Cell. 1999;3:543–553. doi:10.1016/S1097-2765(00)80348-2.
   Google Scholar
• Binder HJ, Filburn B, Floch M. Bile-acid inhibition of intestinal anaerobic organisms. Am J Clin Nutr. 1975;28:119–125. doi:10.1093/ajcn/28.2.119.
   Google Scholar
• Kishinaka M, Umeda A, Kuroki S. High-concentrations of conjugated bile-acids inhibit bacterial growth of Clostridium perferingens and induce its extracellular cholyglycine hydrolase. Steroids. 1994;59:485–489. doi:10.1016/0039-128X(94)90062-0.
   Google Scholar
• Kurdi P, Kawanishi K, Mizutani K, Yokota A. Mechanism of growth inhibition by free bile acids in Lactobacilli and Bifidobacteria. J Bacteriol. 2006;188:1979–1986. doi:10.1128/JB.188.5.1979-1986.2006.
   Google Scholar
• Sung JY, Shaffer EA, Costerton JW. Antibacterial activity of bile salts against common biliary pathogens-effects of hydrophobicity of the molecule and in the presence of phospholipids. Digest Dis Sci. 1993;38:2104–2112. doi:10.1007/BF01297092.
   Google Scholar
• Marion S, Studer N, Desharnais L, Menin L, Escrig S, Meibom A, Hapfelmeier S, Bernier-Latmani R. In vitro and in vivo characterization of Clostridium scindens bile acid transformations. Gut Microbes. 2019;10:481–503. doi:10.1080/19490976.2018.1549420.
   Google Scholar
• Kang JD, Myers CJ, Harris SC, Kakiyama G, Lee IK, Yun BS, Matsuzaki K, Furukawa M, Min HK, Bajaj JS, et al. Bile acid 7 alpha-dehydroxylating gut bacteria secrete antibiotics that inhibit clostridium difficile: role of secondary bile acids. Cell Chem Biol. 2019;26:27–34. doi:10.1016/j.chembiol.2018.10.003.
   Google Scholar
• Ridlon JM, Devendran S, Alves JM, Doden H, Wolf PG, Pereira GV, Ly L, Volland A, Takei H, Nittono H, et al. The ‘in vivo lifestyle’ of bile acid 7α-dehydroxylating bacteria: comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice. Gut Microbes. 2019;9:1–24. doi:10.1080/19490976.2019.1618173.
   Google Scholar
• Perez MJ, Briz O. Bile-acid-induced cell injury and protection. World J Gastroentero. 2009;15:1677–1689. doi:10.3748/wjg.15.1677.
   Google Scholar
• Ruiz L, Margolles A, Sanchez B. Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Front Microbiol. 2013;4:396.
   Google Scholar
• Hyronimus B, Le Marrec C, Sassi AH, Deschamps A. Acid and bile tolerance of spore-forming lactic acid bacteria. Int J Food Microbiol. 2000;61:193–197. doi:10.1016/S0168-1605(00)00366-4.
   Google Scholar
• Sun LL, Xie C, Wang G, Wu Y, Wu Q, Wang XM, Liu J, Deng Y, Xia J, Chen B, et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med. 2018;24:1919–1929. doi:10.1038/s41591-018-0222-4.
   Google Scholar
• Ze XL, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. Isme J. 2012;6:1535–1543. doi:10.1038/ismej.2012.4.
   Google Scholar
• Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, Latour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. P Natl Acad Sci USA. 2001;98:3369–3374. doi:10.1073/pnas.051551698.
   Google Scholar
• Ridlon JM, Bajaj JS. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta Pharm Sin B. 2015;5:99–105. doi:10.1016/j.apsb.2015.01.006.
   Google Scholar
• Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, Sayin SI, Perino A, Brighton CA, Sebti Y, Kluza J, Briand O, et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun. 2015;6:7629.
   Google Scholar
• Chiang JYL. Bile acid metabolism and signaling. Compr Physiol. 2013;3:1191–1212.
   Google Scholar
• Attili AF, Angelico M, Cantafora A, Alvaro D, Capocaccia L. Bile acid-induced liver toxicity-relation to the hydrophobichydrophilic balance of bile acids. Med Hypotheses. 1986;19:57–69. doi:10.1016/0306-9877(86)90137-4.
   Google Scholar
• Delzenne NM, Calderon PB, Taper HS, Roberfroid MB. Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat-in vivo and in vitro studies. Toxicol Lett. 1992;61:291–304. doi:10.1016/0378-4274(92)90156-E.
   Google Scholar
• Tsuda H, Masui T, Imaida K, Fukushima S, Ito N. Promotive effect of primary and secondary bile acids on the induction of Gamma-glutamyl-transferase transpeptidase-positive liver-cell foci as a possible endogenous factor for hepatocarcinogensis in rats. Gann. 1984;75:871–875.
   Google Scholar
• Hofmann AF. Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity. Drug Metab Rev. 2004;36:703–722. doi:10.1081/DMR-200033475.
   Google Scholar
• Carey JB, Williams G. Metabolism of lithocholic acid in bile fistula patients. J Clin Invest. 1963;42:450-&. doi:10.1172/JCI104733.
   Google Scholar
• Sannasiddappa TH, Lund PA, Clarke SR. In Vitro antibacterial activity of unconjugated and conjugated bile salts on staphylococcus aureus. Front Microbiol. 2017;8:1581.
   Google Scholar
• Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med. 1999;159:2647–2658. doi:10.1001/archinte.159.22.2647.
   Google Scholar
• Bustos AY, de Valdez GF, Fadda S, Taranto MP. New insights into bacterial bile resistance mechanisms: the role of bile salt hydrolase and its impact on human health. Food Res Int. 2018;112:250–262. doi:10.1016/j.foodres.2018.06.035.
   Google Scholar
• Begley M, Gahan CGM, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev. 2005;29:625–651. doi:10.1016/j.femsre.2004.09.003.
   Google Scholar
• Miller SI. Antibiotic resistance and regulation of the gram-negative bacterial outer membrane barrier by host innate immune molecules. Mbio. 2016;7:e01541–16.
   Google Scholar
• Sanchez B, Champomier-Verges MC, Stuer-Lauridsen B, Ruas-Madiedo P, Anglade P, Baraige F, de Los Reyes-gavilan CG, Johansen E, Zagorec M, Margolles A, et al. Adaptation and response of Bifidobacterium animalis subsp lactis to bile: a proteomic and physiological approach. Appl Environ Microbiol. 2007;73:6757–6767. doi:10.1128/AEM.00637-07.
   Google Scholar
• Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555:623-+. doi:10.1038/nature25979.
   Google Scholar
• Tian Y, Nichols RG, Cai JW, Patterson AD, Cantorna MT. Vitamin A deficiency in mice alters host and gut microbial metabolism leading to altered energy homeostasis. J Nutr Biochem. 2018;54:28–34. doi:10.1016/j.jnutbio.2017.10.011.
   Google Scholar
• Maurice CF, Turnbaugh PJ. Quantifying and identifying the active and damaged subsets of indigenous microbial communities. In: DeLong EF, editor. Microbial metagenomics, metatranscriptomics, and metaproteomics. Methods in Enzymology. 2013. p. 91–107.
   Google Scholar
• Cai JW, Nichols RG, Koo I, Kalikow ZA, Zhang LM, Tian Y, Zhang J, Smith PB, Patterson AD. multiplatform physiologic and metabolic phenotyping reveals microbial toxicity. Msystems. 2018;3:e00123–18.
   Google Scholar
• Maurice CF, Haiser HJ, Turnbaugh PJ. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell. 2013;152:39–50. doi:10.1016/j.cell.2012.10.052.
   Google Scholar
• Sarafian MH, Lewis MR, Pechlivanis A, Ralphs S, McPhail MJW, Patel VC, Dumas M-E, Holmes E, Nicholson JK. Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry. Anal Chem. 2015;87:9662–9670. doi:10.1021/acs.analchem.5b01556.
   Google Scholar
• Kolek J, Branska B, Drahokoupil M, Patakova P, Melzoch K. Evaluation of viability, metabolic activity and spore quantity in clostridial cultures during ABE fermentation. FEMS Microbiol Rev. 2016;363: 1–7.
   Google Scholar
• Shi XH, Xiao CN, Wang YL, Tang HR. Gallic acid intake induces alterations to systems metabolism in rats. J Proteome Re. 2013;12:991–1006. doi:10.1021/pr301041k.
   Google Scholar
• Tian Y, Zhang LM, Wang YL, Tang HR. Age-related topographical metabolic signatures for the rat gastrointestinal contents. J Proteome Res. 2012;11:1397–1411. doi:10.1021/pr2011507.
   Google Scholar
• Fang H, Gough J. supraHex: an R/Bioconductor package for tabular omics data analysis using a supra-hexagonal map. Biochem Bioph Res Comm. 2014;443:285–289. doi:10.1016/j.bbrc.2013.11.103.
   Google Scholar
• Allman EL, Painter HJ, Samra J, Carrasquilla M, Llinas M. metabolomic profiling of the malaria box reveals antimalarial target pathways. Antimicrob Agents Chemother. 2016;60:6635–6649. doi:10.1128/AAC.01224-16.
   Google Scholar
• Tsugawa H, Cajka T, Kind T, Ma Y, Higgins B, Ikeda K, Kanazawa M, VanderGheynst J, Fiehn O, Arita M, et al. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods. 2015;12:523-+. doi:10.1038/nmeth.3393.
   Google Scholar
• Barupal DK, Haldiya PK, Wohlgemuth G, Kind T, Kothari SL, Pinkerton KE, Fiehn O. MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinf. 2012;13:99.
   Google Scholar
• Hartman AL, Lough DM, Barupal DK, Fiehn O, Fishbein T, Zasloff M, Eisen JA. Human gut microbiome adopts an alternative state following small bowel transplantation. P Natl Acad Sci USA. 2009;106:17187–17192. doi:10.1073/pnas.0904847106.
   Google Scholar
• Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504. doi:10.1101/gr.1239303.
   Google Scholar